yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33411708-8BB71466-89BD-438C-B5AC-150DEE108F30
Q33411708-8BB71466-89BD-438C-B5AC-150DEE108F30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411708-8BB71466-89BD-438C-B5AC-150DEE108F30
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.
P2860
Q33411708-8BB71466-89BD-438C-B5AC-150DEE108F30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411708-8BB71466-89BD-438C-B5AC-150DEE108F30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f667c9c6e2cfc6f54add505d232fb5e6308fa647
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.